Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients With Cancer

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00617-15
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2015English

Treatment of Gram - Positive Infections in Critically Ill Patients

BMC Infectious Diseases
Infectious Diseases
2014English

Effectiveness of Oral Antibiotics for Definitive Therapy of Non-Staphylococcal Gram-Positive Bacterial Bloodstream Infections

Therapeutic Advances in Infectious Disease
2019English

Gram Positive Bacterial Infections in Immunocompromised Patients With HIV Infection

BMC Infectious Diseases
Infectious Diseases
2013English

Daptomycin Treatment in Vascular Graft Gram-Positive Infections

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2018English

Comparative in Vitro Activities of Trovafloxacin (CP-99,219) Against 445 Gram-Positive Isolates From Patients With Endocarditis and Those With Other Bloodstream Infections.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

DALBACEN Cohort: Dalbavancin as Consolidation Therapy in Patients With Endocarditis and/or Bloodstream Infection Produced by Gram-Positive Cocci

Annals of Clinical Microbiology and Antimicrobials
MedicineInfectious DiseasesMicrobiology
2019English

Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2020English

Daptomycin Therapy for Gram-Positive Bacterial Infections: A Retrospective Study of 30 Cardiac Surgery Patients

Critical Care
Critical CareIntensive Care Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy